Article

Alcon, Advanced Medical Optics agree to cross-licensing arrangement

Alcon Laboratories and Advanced Medical Optics (AMO) have agreed to a patent cross-licensing arrangement relating to lubricious coatings for IOL insertion devices and one-piece IOL haptic designs

Huenenberg, Switzerland and Santa Ana, CA-Alcon Laboratories and Advanced Medical Optics (AMO) have agreed to a patent cross-licensing arrangement relating to lubricious coatings for IOL insertion devices and one-piece IOL haptic designs, the companies said in prepared statements.

AMO said it will pay Alcon $10 million for worldwide licenses to share Alcon's patents relating to single-piece IOLs with essentially the same design as AMO's one-piece lens (Tecnis, Model ZCB00).

Meanwhile, Alcon said it will pay AMO $31 million for non-exclusive, worldwide licenses under two families of patents owned by AMO for Alcon's insertion devices (Monarch and AcrySert IOL). The lump-sum payment also includes any future coating systems of a similar type that Alcon may develop, according to the company.

The IOL has been designated as a New Technology Intraocular Lens (NTIOL) by the Centers for Medicare and Medicaid Services, which further recognized the lens as a member of the Reduced Spherical Aberration NTIOL subset and approved it for reimbursement status that provides for additional Medicare reimbursement of $50 per lens for ambulatory surgical centers. AMO launched the IOL in Europe in September 2007. The license deal extends to future IOL models using the same design platform.

All other terms of the agreement are confidential, and both companies told Ophthalmology Times they were unable to discuss the settlement beyond their prepared statements.

"Our intellectual property has been and continues to be an important asset to AMO," said Steve Chesterman, manager, corporate communications for AMO. However, he clarified, "neither party pursued litigation."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.